![](/img/cover-not-exists.png)
Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer
David S. Ettinger, Dianne M. Finkelstein, Martin D. Abeloff, Yuang-Chi Chang, Thomas J. Smith, Martin M. Oken, John C. RuckdeschelVolume:
8
Language:
english
Pages:
3
DOI:
10.1007/bf00177255
Date:
May, 1990
File:
PDF, 171 KB
english, 1990